Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

NCT00064025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

NETWORK

Sponsor class

Conditions

Endometrial Adenocarcinoma
Endometrial Adenosquamous Carcinoma
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
Recurrent Uterine Corpus Carcinoma
Stage I Uterine Corpus Cancer
Stage II Uterine Corpus Cancer
Stage III Uterine Corpus Cancer
Stage IV Uterine Corpus Cancer

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Medroxyprogesterone
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]